Suppr超能文献

用于阿霉素递送的组蛋白去乙酰化酶抑制剂共轭聚合物前药胶束

HDAC Inhibitor Conjugated Polymeric Prodrug Micelles for Doxorubicin Delivery.

作者信息

Senevirathne Suchithra A, Washington Katherine E, Miller Jason B, Biewer Michael C, Oupicky David, Siegwart Daniel J, Stefan Mihaela C

机构信息

Department of Chemistry, University of Texas at Dallas, Richardson, TX, USA.

Department of Biochemistry, University of Texas Southwestern Medical Center, Simmons Comprehensive Cancer Center, Dallas, TX, USA.

出版信息

J Mater Chem B. 2017 Mar 21;5(11):2106-2114. doi: 10.1039/C6TB03038F. Epub 2017 Feb 20.

Abstract

Amphiphilic diblock copolymers bearing histone deacetylase inhibitors (HDACi) (4-phenyl butyric acid and valproic acid) were synthesized by the ring-opening polymerization of γ-4-phenylbutyrate-ε-caprolactone (PBACL), γ-valproate-ε-caprolactone (VPACL), and ε-caprolactone (CL) from a poly(ethylene glycol) macroinitiator (PEG). These amphiphilic diblock copolymers self-assembled into stable pro-drug micelles and demonstrated excellent biocompatibility. High loading of doxorubicin (DOX) up to 5.1 wt% was achieved. Optimized micelles enabled sustained drug release in a concentration-dependent manner over time to expand the therapeutic window of cytotoxic small molecule drugs.

摘要

通过聚乙二醇(PEG)大分子引发剂引发γ-4-苯基丁酸-ε-己内酯(PBACL)、γ-丙戊酸-ε-己内酯(VPACL)和ε-己内酯(CL)的开环聚合反应,合成了带有组蛋白去乙酰化酶抑制剂(HDACi)(4-苯基丁酸和丙戊酸)的两亲性二嵌段共聚物。这些两亲性二嵌段共聚物自组装成稳定的前药胶束,并表现出优异的生物相容性。实现了高达5.1 wt%的阿霉素(DOX)高负载量。优化后的胶束能够随着时间以浓度依赖的方式实现药物的持续释放,从而扩大细胞毒性小分子药物的治疗窗口。

相似文献

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验